| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
102,087,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
3,941,702 |
Avg
Vol: |
1,828,512 |
| 52
Week Range: |
$45.85 - $45.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2015-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,100 |
33,034 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$65,428 |
D/D |
(1,427) |
62,037 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,832 |
63,464 |
|
- |
|
| Rogus Joseph J |
SVP, GTO & Supply Chain Mngmt |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$32,324 |
D/D |
(705) |
19,881 |
|
- |
|
| Rogus Joseph J |
SVP, GTO & Supply Chain Mngmt |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,567 |
20,586 |
|
- |
|
| Nader Francois |
President, CEO and Director |
• • – |
2015-02-12 |
4 |
D |
$45.85 |
$226,637 |
D/D |
(4,943) |
265,254 |
|
- |
|
| Nader Francois |
President, CEO and Director |
• • – |
2015-02-12 |
4 |
OE |
$0.00 |
$151,769 |
D/D |
43,804 |
270,197 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$71,709 |
D/D |
(1,564) |
38,278 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,832 |
39,842 |
|
- |
|
| Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$43,878 |
D/D |
(957) |
24,934 |
|
- |
|
| Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,787 |
25,891 |
|
- |
|
| Graf Susan E |
VP,Corp Development & Strategy |
• – – |
2015-02-12 |
4 |
D |
$45.85 |
$22,191 |
D/D |
(484) |
4,761 |
|
- |
|
| Graf Susan E |
VP,Corp Development & Strategy |
• – – |
2015-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,445 |
5,245 |
|
- |
|
| Garceau Roger |
SVP &CMO |
• – – |
2015-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
41,448 |
|
- |
|
| Graf Susan E |
VP, Corp Development & Strateg |
• – – |
2015-02-10 |
4 |
S |
$45.87 |
$307,834 |
D/D |
(6,711) |
3,800 |
|
- |
|
| Graf Susan E |
VP, Corp Development & Strateg |
• – – |
2015-02-10 |
4 |
OE |
$14.90 |
$99,994 |
D/D |
6,711 |
10,511 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2015-02-07 |
4 |
D |
$45.85 |
$144,336 |
D/D |
(3,148) |
59,632 |
|
- |
|
| Beshar Luke M |
EVP & CFO |
• – – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
8,967 |
62,780 |
|
- |
|
| Rogus Joseph J |
SVP, GTO & Supply Chain Mngmt |
• – – |
2015-02-07 |
4 |
D |
$45.85 |
$51,902 |
D/D |
(1,132) |
19,019 |
|
- |
|
| Rogus Joseph J |
SVP, GTO & Supply Chain Mngmt |
• – – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,767 |
20,151 |
|
- |
|
| Nader Francois |
President, CEO and Director |
• • – |
2015-02-07 |
4 |
D |
$45.85 |
$333,009 |
D/D |
(7,263) |
226,393 |
|
- |
|
| Nader Francois |
President, CEO and Director |
• • – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,301 |
233,656 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2015-02-07 |
4 |
D |
$45.85 |
$249,332 |
D/D |
(5,438) |
36,010 |
|
- |
|
| Garceau Roger |
SVP & CMO |
• – – |
2015-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,168 |
41,448 |
|
- |
|
| Pauwels Eric |
President, NPS Pharma Intl |
• – – |
2015-02-07 |
4 |
D |
$45.85 |
$76,203 |
D/D |
(1,662) |
23,104 |
|
- |
|
574 Records found
|
|
Page 2 of 23 |
|
|
